A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sirolimus-31,42-Diester Impurity - Request Quote

Picture of Sirolimus-31,42-Diester Impurity

Sirolimus-31,42-Diester Impurity

SZ CAT No:SZ-R025023
CAS No
NA
Mol.F.
C61H95NO19
Mol.Wt.
1146.4
Inv. Status
Synthesis on demand

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Sirolimus-31,42-Diester Impurity is chemically . Sirolimus-31,42-Diester Impurity is supplied with detailed characterization data compliant with regulatory guideline. Sirolimus-31,42-Diester Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rapamycin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Sirolimus-31,42-Diester Impurity

Purchase Sirolimus-31,42-Diester Impurity

Sirolimus-31,42-Diester Impurity suppliers

Sirolimus-31,42-Diester Impurity manufacturers

Sirolimus-31,42-Diester Impurity price

Order Sirolimus-31,42-Diester Impurity

Enquire Sirolimus-31,42-Diester Impurity

Sirolimus-31,42-Diester Impurity cost

Sirolimus-31,42-Diester Impurity Supplier

Sirolimus-31,42-Diester Impurity Distributor

Sirolimus-31,42-Diester Impurity for Method Validation

Rapamycin Reference Standard

Sirolimus-31,42-Diester Impurity for ANDA Filing

Sirolimus-31,42-Diester Impurity for Forced Degradation Studies

Sirolimus-31,42-Diester Impurity Identification Standards

Sirolimus-31,42-Diester Impurity for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,